Matthew Cohen
Associate @ Pangaea Ventures
Matthew Cohen is a Series C investor at Pangaea Ventures focused on Pharmaceutical and Advanced Materials. Matthew Cohen brings experience and a passion for working with advanced materials and cleantech in both industry and academia. Prior to joining Pangaea Ventures, Matthew worked in companies and ventures involved in printed electronics utilizing nanotechnology, biotechnology and environmental bioremediation. He performed various functions thatincluded business development, R&D, product development, customer technical support, and international launch strategies while gaining valuable start-up understanding.Matt holds an MPhil in Micro- & Nanotechnology Enterprise from the University of Cambridge and graduated summa cum laude from the University of Pennsylvania with a BSE in Materials Science & Engineering.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Matthew Cohen invests in
Stages Matthew Cohen invests in
Countries Matthew Cohen invests in
Investment Focus
Industry
- Pharmaceutical 1 (100%)
- Advanced Materials 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TruTag Technologies
|
TruTag Technologies, Inc. is a leading authentication and technology solution provider serving businesses and governments around the world. TruTag has the most advanced precision-fabricated, cGMP nano-porous silica manufacturing operation in the world for product authentication across a broad range of industries including pharmaceuticals, food,consumer products, and industrial & electronic parts. TruTag’s authentication platform is complemented by its’ advanced hyperspectral imaging technology, which is focused on providing powerful next-generation inline quality assurance solutions and diagnostics.TruTag Technologies has been recognized by the SPIE Prism Awards, the Edison Awards, Fast Company, R&D 100, and was selected a Technology Pioneer by the World Economic Forum as one of the most influential technology companies in the world. | Series C / Oct 17, 2019 |
Co-Investors
About Pangaea Ventures
Pangaea Ventures invests in companies solving fundamental problems in the world with advanced materials and hard technology; Impact Investor
Pangaea Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Erickson
General Partner
|
|||
|
Matthew Cohen
Associate
|
|||
Purnesh Seegopaul
General Partner
|
|||
Tracy Hedberg
Director, Finance and Administration
|
|||
Andrew Haughian
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Matthew Cohen invest in?
Matthew Cohen invests primarily in Pharmaceutical, Advanced Materials and Health Diagnostics startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Matthew Cohen last invest?
The most recent investment recorded for Matthew Cohen closed in Oct 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
